{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:25:31Z","timestamp":1761863131600},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1996,8,15]]},"abstract":"\n Background<\/jats:italic>\n We hypothesized that the response of a myocardial segment to maximal dobutamine reflects not only maximal blood flow but also tethering, metabolic, and \u03b2-blocker status.\n <\/jats:p>\n \n Methods and Results<\/jats:italic>\n Patients with stable ischemic heart disease (n=27) had positron emission tomographic measurement of blood flow at rest and with adenosine, and echocardiography at rest and with dobutamine. Positron emission tomographic measurement of [\n 18<\/jats:sup>\n F]fluorodeoxyglucose myocardial distribution also was made. Adenosine blood flow in segments that contracted normally at peak dobutamine was similar to that of segments that became hypokinetic (1.06\u00b10.72 versus 1.02\u00b10.77 mL\u00b7g\n \u22121<\/jats:sup>\n \u00b7min\n \u22121<\/jats:sup>\n ). Segments that became akinetic failed to augment blood flow (0.68\u00b10.30 mL\u00b7g\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n \u00b7min\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n ). Fluorodeoxyglucose\u2013blood flow mismatch was more common in segments with abnormal wall motion at peak dobutamine (24 of 59, 41%) versus those that contracted normally (63 of 269, 23%; \u03c7\n 2<\/jats:sup>\n , 7.40;\n P<\/jats:italic>\n <.01). In patients off \u03b2-blockers, segments that contracted normally at peak dobutamine increased blood flow with adenosine (0.70\u00b10.31 to 0.86\u00b10.46 mL\u00b7g\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n \u00b7min\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n ;\n P<\/jats:italic>\n <.05), whereas those that became abnormal did not (0.63\u00b10.24 to 0.65\u00b10.19 mL\u00b7g\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n \u00b7min\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n ;\n P<\/jats:italic>\n =NS). Segments of patients on \u03b2-blockers that contracted normally at peak dobutamine increased blood flow with adenosine (0.78\u00b10.31 to 1.10\u00b10.70 mL\u00b7g\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n \u00b7min\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n ;\n P<\/jats:italic>\n <.05), as did segments that became abnormal (0.74\u00b10.34 to 1.06\u00b10.82 mL\u00b7g\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n \u00b7min\n \u2212<\/jats:sup>\n 1<\/jats:sup>\n ;\n P<\/jats:italic>\n =NS). However, segments adjacent to ones with abnormal wall motion at rest had higher frequency of abnormal response at peak dobutamine in groups on (48% versus 16%; \u03c7\n 2<\/jats:sup>\n , 14.1;\n P<\/jats:italic>\n <.001) and off (51% versus 21%; \u03c7\n 2<\/jats:sup>\n , 10.9;\n P<\/jats:italic>\n <.01) \u03b2-blockers.\n <\/jats:p>\n \n Conclusions<\/jats:italic>\n Augmented contraction at maximal dobutamine depends not only on increased myocardial blood flow but also on tethering, metabolic, and \u03b2-blocker status. Furthermore, impaired flow reserve does not preclude a normal response to maximal dobutamine, since blood flow need not increase greatly to meet demand.\n <\/jats:p>","DOI":"10.1161\/01.cir.94.4.643","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:34:42Z","timestamp":1339461282000},"page":"643-650","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Factors Influencing Regional Myocardial Contractile Response to Inotropic Stimulation"],"prefix":"10.1161","volume":"94","author":[{"given":"Hal A.","family":"Skopicki","sequence":"first","affiliation":[{"name":"the Departments of Medicine (Cardiac Unit), Radiology, and Nuclear Medicine, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Abraham","sequence":"additional","affiliation":[{"name":"the Departments of Medicine (Cardiac Unit), Radiology, and Nuclear Medicine, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil J.","family":"Weissman","sequence":"additional","affiliation":[{"name":"the Departments of Medicine (Cardiac Unit), Radiology, and Nuclear Medicine, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K.","family":"Mukerjee","sequence":"additional","affiliation":[{"name":"the Departments of Medicine (Cardiac Unit), Radiology, and Nuclear Medicine, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel M.","family":"Alpert","sequence":"additional","affiliation":[{"name":"the Departments of Medicine (Cardiac Unit), Radiology, and Nuclear Medicine, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Fischman","sequence":"additional","affiliation":[{"name":"the Departments of Medicine (Cardiac Unit), Radiology, and Nuclear Medicine, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Picard","sequence":"additional","affiliation":[{"name":"the Departments of Medicine (Cardiac Unit), Radiology, and Nuclear Medicine, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Gewirtz","sequence":"additional","affiliation":[{"name":"the Departments of Medicine (Cardiac Unit), Radiology, and Nuclear Medicine, Massachusetts General Hospital, Harvard Medical School, Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","doi-asserted-by":"crossref","unstructured":"Canty JMJ Klocke FJ. Reductions in regional myocardial function at rest in conscious dogs with chronically reduced regional coronary artery pressure. Circ Res. 1987;61(suppl II):II-107-II-116.","DOI":"10.1161\/res.61.5_supplement.ii-107"},{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.47.2.7397952"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Bache RJ Schwartz JS. Myocardial blood flow during exercise after gradual coronary occlusion in the dog. Am J Physiol. 1983;245(Heart Circ Physiol 14):H131-H138.","DOI":"10.1152\/ajpheart.1983.245.1.H131"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.46.2.190"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(78)90819-6"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/20.7.504"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.53.3.6883652"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.52.6.716"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90436-0"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.69.5.6705159"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00795114"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.3.1076"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(89)90685-6"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.86.6.1451239"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90629-7"},{"key":"e_1_3_1_16_2","first-page":"163","volume":"31","year":"1990","unstructured":"Rosenspire KC, Schwaiger M, Magner TJ, Hutchins GD, Sutorik A, Kuhl DE. Metabolic fate of 13-N-ammonia in human and canine blood. J Nucl Med. 1990;31:163-167.","journal-title":"J Nucl Med"},{"key":"e_1_3_1_17_2","first-page":"77P","volume":"35","year":"1994","unstructured":"Gewirtz H, Fischman A, Alpert N. Validation of K1 parametric images obtained from dynamic 13-NH3 PET images: comparison to K1 values obtained with a standard non-linear estimation program. J Nucl Med. 1994;35:77P. Abstract.","journal-title":"J Nucl Med"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00450-5"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.87.2.8425283"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90373-9"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.50.3.7060231"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.85.5.1572040"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0033-0620(81)90019-0"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107676"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.78.3.729"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.67.6.2245507"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.71.3.1499111"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","unstructured":"Vanoverschelde JLJ Wijns W Essamri B Bol A Robert A Labar D Cogneau M Michel C Melin JA. Hemodynamic and mechanical determinants of myocardial O2 consumption in normal human heart: effects of dobutamine. Am J Physiol. 1993;265(Heart Circ Physiol 34):H1884-H1892.","DOI":"10.1152\/ajpheart.1993.265.6.H1884"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.8.2333"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.89.2.8313564"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.79.4.2784361"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.91.7.1944"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90237-J"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.80.5.2805269"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.70.2.6733880"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.76.4.3652428"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0894-7317(05)80352-9"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90016-0"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.94.4.643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T15:51:39Z","timestamp":1715529099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.94.4.643"}},"subtitle":["Analysis in Humans With Stable Ischemic Heart Disease"],"short-title":[],"issued":{"date-parts":[[1996,8,15]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,8,15]]}},"alternative-id":["10.1161\/01.CIR.94.4.643"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.94.4.643","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,8,15]]},"assertion":[{"value":"1995-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-02-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}